Fifth Third Bancorp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541M Sell
2,151,394
-46,500
-2% -$10M 0.88% 18
2026
Q1
$478M Buy
2,197,894
+706,723
+47% +$157M 0.87% 19
2025
Q4
$341M Buy
1,491,171
+12,110
+0.8% +$2.76M 1.08% 15
2025
Q3
$342M Buy
1,479,061
+24,183
+2% +$4.92M 1.09% 16
2025
Q2
$270M Buy
1,454,878
+14,401
+1% +$2.68M 0.93% 21
2025
Q1
$302M Sell
1,440,477
-27,716
-2% -$5.39M 1.15% 16
2024
Q4
$261M Sell
1,468,193
-151,013
-9% -$27.8M 0.95% 19
2024
Q3
$320M Sell
1,619,206
-2,873
-0.2% -$536K 1.16% 16
2024
Q2
$278M Sell
1,622,079
-24,463
-1% -$4.05M 1.06% 18
2024
Q1
$300M Buy
1,646,542
+9,254
+0.6% +$1.59M 1.17% 18
2023
Q4
$254M Sell
1,637,288
-30,159
-2% -$4.4M 1.08% 18
2023
Q3
$249M Buy
1,667,447
+843
+0.1% +$124K 1.15% 16
2023
Q2
$225M Buy
1,666,604
+17,130
+1% +$2.51M 0.99% 21
2023
Q1
$263M Sell
1,649,474
-31,566
-2% -$4.83M 1.22% 15
2022
Q4
$272M Buy
1,681,040
+50,702
+3% +$7.77M 1.31% 14
2022
Q3
$219M Buy
1,630,338
+2,682
+0.2% +$385K 1.14% 18
2022
Q2
$249M Buy
1,627,656
+40,728
+3% +$6.22M 1.21% 18
2022
Q1
$257M Sell
1,586,928
-16,783
-1% -$2.44M 1.05% 19
2021
Q4
$217M Buy
1,603,711
+43,942
+3% +$5.19M 0.84% 26
2021
Q3
$168M Buy
1,559,769
+65,548
+4% +$7.49M 0.73% 29
2021
Q2
$168M Sell
1,494,221
-60,201
-4% -$6.78M 0.74% 28
2021
Q1
$168M Buy
1,554,422
+50,671
+3% +$5.42M 0.78% 26
2020
Q4
$161M Buy
1,503,751
+56,448
+4% +$5.42M 0.79% 26
2020
Q3
$127M Buy
1,447,303
+40,361
+3% +$3.8M 0.7% 32
2020
Q2
$138M Buy
1,406,942
+132,957
+10% +$11.7M 0.83% 24
2020
Q1
$97.1M Buy
1,273,985
+70,234
+6% +$5.98M 0.69% 30
2019
Q4
$107M Buy
1,203,751
+76,561
+7% +$6.36M 0.59% 44
2019
Q3
$85.4M Buy
1,127,190
+41,999
+4% +$2.88M 0.51% 51
2019
Q2
$78.9M Sell
1,085,191
-10,155
-0.9% -$798K 0.48% 53
2019
Q1
$88.3M Sell
1,095,346
-194,691
-15% -$15.9M 0.57% 45
2018
Q4
$119M Sell
1,290,037
-5
-0% -$440 0.86% 27
2018
Q3
$122M Sell
1,290,042
-128,657
-9% -$12.2M 0.78% 29
2018
Q2
$131M Buy
1,418,699
+45,409
+3% +$4.43M 0.89% 25
2018
Q1
$130M Buy
1,373,290
+29,441
+2% +$3.23M 0.89% 26
2017
Q4
$130M Sell
1,343,849
-70,195
-5% -$6.62M 0.88% 24
2017
Q3
$126M Buy
1,414,044
+26,289
+2% +$2M 0.9% 21
2017
Q2
$101M Sell
1,387,755
-13,678
-1% -$920K 0.74% 28
2017
Q1
$91.3M Buy
1,401,433
+145,902
+12% +$9.17M 0.69% 31
2016
Q4
$78.6M Sell
1,255,531
-45,492
-3% -$2.78M 0.63% 36
2016
Q3
$82.1M Buy
1,301,023
+20,846
+2% +$1.35M 0.68% 31
2016
Q2
$79.3M Sell
1,280,177
-18,526
-1% -$1.13M 0.67% 33
2016
Q1
$74.2M Buy
1,298,703
+44,077
+4% +$2.46M 0.64% 37
2015
Q4
$74.3M Sell
1,254,626
-22,843
-2% -$1.32M 0.65% 32
2015
Q3
$69.5M Buy
1,277,469
+37,529
+3% +$2.44M 0.65% 33
2015
Q2
$83.3M Sell
1,239,940
-56,974
-4% -$3.72M 0.73% 29
2015
Q1
$75.9M Sell
1,296,914
-176,818
-12% -$10.7M 0.66% 32
2014
Q4
$96.4M Buy
1,473,732
+47,400
+3% +$2.99M 0.82% 24
2014
Q3
$82.4M Buy
1,426,332
+20,535
+1% +$1.14M 0.75% 29
2014
Q2
$79.3M Buy
1,405,797
+60,573
+5% +$3.18M 0.72% 31
2014
Q1
$69.1M Sell
1,345,224
-41,201
-3% -$2.08M 0.65% 34
2013
Q4
$73.2M Buy
1,386,425
+10,432
+0.8% +$513K 0.71% 33
2013
Q3
$61.5M Sell
1,375,993
-48,754
-3% -$2.16M 0.63% 37
2013
Q2
$58.9M Buy
+1,424,747
New +$62.3M 0.63% 37

Other funds holding ABBV

Fifth Third Bancorp's ABBV Position: Q2 2026 in Review

Fifth Third Bancorp reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $10M and leaving 2,151,394 shares worth $541M. The position accounts for 0.88% of the portfolio, ranked #18.

Fifth Third Bancorp first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fifth Third Bancorp held 2,151,394 shares of AbbVie worth $541M as of Q2 2026.
  • Fifth Third Bancorp sold 46,500 AbbVie shares in Q2 2026, an estimated $10M.
  • AbbVie made up 0.88% of Fifth Third Bancorp's portfolio in Q2 2026, its #18 holding.
  • Fifth Third Bancorp first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.